ALX Oncology
Julia Leontyeva is an experienced finance professional currently serving as Corporate Controller at ALX Oncology since August 2024. Prior to this role, Julia held the position of Senior Director of Technical Accounting and Reporting at Allogene Therapeutics from June 2022 to August 2024, and served as Director of Global Revenue and Cost Accounting at FibroGen, Inc. from February 2021 to June 2022. Julia's extensive career began at EY, where a progression from Assurance Staff to Senior Manager included participation in a global rotation program in San Francisco. Julia's educational background includes a Bachelor's degree in International Economics from Ural State University named after A.M. Gorky, completed in 2007.
This person is not in any teams
ALX Oncology
ALX Oncology is a publicly traded, clinical-stage immuno-oncology company focused on helping patients fight cancer by developing therapies that block the CD47 checkpoint pathway and bridge the innate and adaptive immune system.